Contract signedUnited KingdomGoods
Capital Purchase of Genetic Screening Processor and Panthera Punch
- Published
- Published 3 June 2026
Overview
The Cardiff and Vale University Health Board have a requirement to replace the current Newborn Screening Analysers used for CHT and CF screening. The current equipment is at the end of life, as well as nearing discontinuation. Replacement is required with the newer version, the Revvity Genetic Service Processor (GSP) to ensure continuity of service provision, In addition to replacing the GSP, there is also a need to replace the current Panther multi puncher that is also at the very end of its lifespan
Key details
- Country
- United Kingdom
- Status
- Contract signed
- Category
- Goods
- Procedure
- Limited
- Published
- 3 June 2026
Medical equipmentsAnalysers
Award outcome
- Awarded value
- £511,496
- Award date
- 16 March 2026
- REVVITY (UK) LIMITED
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract
3 June 2026
View notice ↗
Contracting authority
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
BuyerCardiff, United Kingdom
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.